Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

RegenCen vs Royal Medical Center

RegenCen
Graded #334

Higher grade

vs+10.399999999999999
Royal Medical Center
Graded #492

Lower grade

The verdict

RegenCen takes it — 59.8/100 to 49.4/100.

RegenCen grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RegenCen is a women's and menopause-focused practice offering its Medically Guided Weight Loss program with GLP-1 medications including semaglutide and tirzepatide, paired with peptides, metabolic care, and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRegenCen +23
45
22
Dose & formulationRoyal Medical Center +2
40
42
Clinical oversightRegenCen +18
80
62
Labs & monitoringRoyal Medical Center +1
85
86
FulfillmentRegenCen +14
62
48
Contract termsEven
55
55
RegenCen · left barRoyal Medical Center · right bar

The numbers

MetricRegenCenRoyal Medical Center
WeighScore59.8/10049.4/100
GradeCC
Scorecard rank#334#492
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosed$450/mo (2.5 mg dose, compounded)
Coverage2 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
RegenCen

Graded #334 · C

Strengths

  • Virtual consultations by video or phone for MI and FL patients
  • MD-led oversight (Dr. Gustav Lo) plus PA co-founder
  • Menopause Society Certified Practitioners on staff
  • GLP-1 paired with coaching and metabolic care
  • Bundles weight loss with bioidentical hormone therapy

Where it loses points

  • Telehealth limited to Michigan and Florida
  • No published GLP-1 medication pricing
  • No named pharmacy or medication sourcing details
  • Menopause/women's focus rather than weight-loss-only
Royal Medical Center

Graded #492 · C

Strengths

  • Physician founder Dr. Dagoberto Rodriguez, MD — Emory residency, former Coral Springs Medical Center chairman, U Miami faculty
  • Tirzepatide pricing fully itemized by dose tier ($450 / $650 / $800 / $1,100) — more transparent than 'starting at' floors
  • All-inclusive pricing bundles medication, supplies, injections, lab monitoring, and physician follow-ups
  • Broad catalog (HRT, TRT, peptides, ED, hair, vitamins) reflects an established multi-program clinic
  • Florida physician with 30+ years of practice — a strong physician-led care signal

Where it loses points

  • Operating legal entity not disclosed — only the 'Royal Medical Center' brand surfaced
  • Pharmacy partner not named — buyers can't verify licensure or 503A/503B status
  • No LegitScript badge displayed
  • States served not enumerated — site says 'nationwide' with no state list
  • Headline 'starting at $116/mo' conflicts with the actual $450/mo tirzepatide floor

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard